Stoschitzky, K., Stoschitzky, G., Lercher, P., Brussee, H., Lamprecht, G. and Lindner, W. (2016) Propafenone Shows Class IC and Class II Antiarrhythmic Effects. Europace, 18, 568-571.
https://doi.org/10.1093/europace/euv195

has been cited by the following article:

• TITLE: The Treatment of Paroxysmal Supraventricular Tachycardia and Research Progress

  AUTHORS: Jingchao Long, Shiyu Cheng, Shan Deng, Ke Li, Keping Yang

  KEYWORDS: Paroxysmal Supraventricular Tachycardia, Pathophysiological Mechanism, Clinical Diagnosis, Drug Treatment, Interventional Treatment

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.16 No.12, December 8, 2025

  ABSTRACT: Paroxysmal supraventricular tachycardia (PSVT) is a common rapid arrhythmia observed in clinical settings, characterized by abrupt and sustained episodes lasting minutes to hours. It presents significant risks, including heart failure, syncope, shock, and sudden death, profoundly affecting patients’ quality of life. This review explores the epidemiology, pathophysiology, clinical manifestations, and diagnostic approaches of PSVT, emphasizing treatment modalities such as physical therapy, pharmacotherapy, interventional procedures. Additionally, it addresses current obstacles and future prospects in PSVT management to guide clinical practice and research initiatives.